Aardvark Therapeutics, Inc.

San Diego, CA · Founded 2017 · CIK 0001774857 · Biotech · Public

Small-molecule drugs that inhibit hunger to treat metabolic disorders

aardvarktherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$103M
3 Form D · May 2024
29 months since last filing
Contracts
—
No federal contracts on record
Patents
40
4 granted · 36 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$9,000,003
Private capital raisedForm D · SEC$9,060,000
Private capital raisedForm D · SEC$84,999,982
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1253B-TECH CONSULTING, LTD——
1254MIND BIOSCIENCES LLC——
1255TScan Therapeutics—$123M
1256Aardvark Therapeutics, Inc.—$103M
1257Satellite Biosciences, Inc.—$101M
1258GPN THERAPEUTICS, INC.——
1259AYTU BIOSCIENCE, INC—$26M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Jerel BanksDirector
  • Jeffrey ChiDirector
  • Zachary HornbyDirector
  • Henry JiDirector
  • Tien-Li LeeDirector · Executive Officer
  • Bob ShinDirector
  • Nelson SunExecutive Officer
  • Victor TongDirector

Patents

USPTO · 4 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.